Insomnia Treatment in Sugar Land, TX
Sleep is one of the most fundamental regulators of mental health. When it breaks down, everything else follows - mood, concentration, energy, emotional resilience, physical health. Yet insomnia is frequently treated as an afterthought, addressed with a quick prescription for a sleep aid rather than a real investigation into why sleep is disrupted in the first place.
The patients we see at CIP Psychiatry with insomnia usually fall into one of three categories. Some have primary insomnia, which is a standalone sleep disorder where the brain’s sleep-wake system is dysregulated, often reinforced by anxiety about not sleeping. Others have insomnia that is driven by an underlying psychiatric condition: depression, anxiety, PTSD, bipolar disorder, ADHD, or medication side effects. The third category is usually a person that has an undiagnosed or other underlying medical co-morbidity contributing to the insomnia. The treatment for each is different, and getting the diagnosis right is the critical first step.
When Insomnia Becomes a Clinical Problem
Difficulty sleeping is common. Insomnia as a clinical condition means that the difficulty is persistent (at least three nights per week for three months or more), occurs despite adequate opportunity to sleep, and causes meaningful daytime impairment. This includes fatigue, difficulty concentrating, mood disturbance, reduced motivation, or impaired functioning at work or in relationships.
Common patterns include difficulty falling asleep (sleep onset insomnia), waking up repeatedly during the night (sleep maintenance insomnia), waking up too early and being unable to fall back asleep (early morning awakening), or some combination of all three. Each pattern can suggest different underlying mechanisms.
Our Approach to Insomnia
• Identify the root cause. We evaluate for underlying psychiatric conditions, medication side effects, substance use (including caffeine and alcohol), sleep apnea, restless legs syndrome, circadian rhythm disruptions, and behavioral factors. Treating insomnia without understanding what is driving it often leads to chronic dependence on sleep medications without actual improvement in sleep quality.
• Behavioral interventions first. Cognitive-behavioral therapy for insomnia (CBT-I) is the evidence-based first-line treatment. It addresses the behavioral and cognitive patterns that perpetuate insomnia such as things like spending excessive time in bed, irregular sleep schedules, clock-watching, and anxious thoughts about sleep. We incorporate CBT-I principles into our appointments and refer to specialists when more intensive behavioral treatment is indicated.
• Medication when appropriate. When medication is warranted, we use it strategically. We generally try to avoid long-term use of benzodiazepines and z-drugs (like zolpidem) for chronic insomnia because of tolerance, dependence, and rebound insomnia risks. Instead, we may use medications like trazodone, hydroxyzine, gabapentin, or low-dose doxepin depending on the clinical picture. If an underlying condition like depression or anxiety is driving the insomnia, treating that condition often resolves the sleep difficulty as well.
• Sleep hygiene as a foundation. Consistent wake times, limiting screen exposure before bed, optimizing the sleep environment, and strategic use of light exposure are not cure-alls, but they create the conditions under which other treatments work better. We discuss these practically, not as a lecture.
Why CIP Psychiatry for Insomnia Treatment in Sugar Land
• All care provided under the direction of a board-certified psychiatrist
• In-person appointments in Sugar Land and telehealth throughout Texas
• In-network with Aetna, BCBS, Cigna, UnitedHealthcare, Oscar, and Medicare
• New patients typically seen within 1-2 weeks
• Thorough evaluation to find the root cause rather than prescribing a sleep aid by default
• Integration of behavioral and pharmacological approaches
Reviewed by Shehram Majid, MD. Board-Certified Psychiatrist, CIP Psychiatry. Last updated March 2026